CXCL13 and CXCL9 as diagnostic and therapy monitoring markers in central nervous system lymphoma

被引：0
|
作者：
Masouris, I. [1 ]
Pfirnnann, M. [2 ]
Manz, K. [2 ]
Koedeli, U. [1 ]
Von Baumgarten, L. [1 ]
机构：
[1] Ludwig Maximilians Univ Munchen, Dept ofNeurol, Munich, Germany
[2] Ludwig Maximilians Univ Munchen, Fac Med, Inst Med Informat Proc Biometry & Epidemiol, Munich, Germany
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2020年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPR2209
引用
收藏
页码：392 / 392
页数：1
相关论文
共 50 条
  • [41] The synergized diagnostic value of VTQ with chemokine CXCL13 in lung tumors
    Zhang, Xu
    Lu, Yejian
    Huang, Kenan
    Pan, Qingfang
    Jia, Youchao
    Cui, Baoshuan
    Yin, Peipei
    Li, Jianhui
    Ju, Junping
    Fan, Xiangyu
    Tian, Rui
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [42] CXCL13 AS A NOVEL MARKER FOR DIAGNOSIS AND DISEASE MONITORING IN PEDIATRIC PTLD
    Schiffer, L.
    Henke-Gendo, C.
    Wilsdorf, N.
    Haller, H.
    Schiffer, M.
    Klein, C.
    Kreipe, H.
    Maecker-Kolhoff, B.
    TRANSPLANT INTERNATIONAL, 2011, 24 : 57 - 57
  • [43] CXCL13 as a Novel Marker for Diagnosis and Disease Monitoring in Pediatric PTLD
    Schiffer, L.
    Henke-Gendo, C.
    Wilsdorf, N.
    Hussein, K.
    Pape, L.
    Schmitt, C.
    Schiffer, M.
    Haller, H.
    Klein, C.
    Kreipe, H.
    Maecker-Kolhoff, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 187 - 187
  • [44] Discriminating between Lyme neuroborreliosis and other central nervous system infections by use of biomarkers CXCL13 and IL-6
    Leth, Trine Andreasen
    Dessau, Ram Benny
    Moller, Jens Kjolseth
    TICKS AND TICK-BORNE DISEASES, 2022, 13 (05)
  • [45] CXCL13 as a Novel Marker for Diagnosis and Disease Monitoring in Pediatric PTLD
    Schiffer, L.
    Henke-Gendo, C.
    Wilsdorf, N.
    Hussein, K.
    Pape, L.
    Schmitt, C.
    Haller, H.
    Schiffer, M.
    Klein, C.
    Kreipe, H.
    Maecker-Kolhoff, B.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 (06) : 1610 - 1617
  • [46] Urinary Chemokines CXCL9 and CXCL10 Are Noninvasive Markers of Renal Allograft Rejection and BK Viral Infection
    Jackson, J. A.
    Kim, E. J.
    Begley, B.
    Cheeseman, J.
    Harden, T.
    Perez, S. D.
    Thomas, S.
    Warshaw, B.
    Kirk, A. D.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 (10) : 2228 - 2234
  • [47] CXCL13 plus interleukin 10 is highly specific for the diagnosis of CNS lymphoma
    Rubenstein, James L.
    Wong, Valerie S.
    Kadoch, Cigall
    Gao, Hua-Xin
    Barajas, Ramon
    Chen, Lingjing
    Josephson, S. Andrew
    Scott, Brian
    Douglas, Vanja
    Maiti, Mekhala
    Kaplan, Lawrence D.
    Treseler, Patrick A.
    Cha, Soonmee
    Hwang, Jimmy H.
    Cinque, Paola
    Cyster, Jason G.
    Lowell, Clifford
    BLOOD, 2013, 121 (23) : 4740 - 4748
  • [48] CXCL9/10 Elevation in Severe Asthma Is Refractory to Corticosteroid Therapy
    Gauthier, M.
    Fajt, M. L.
    Ray, A.
    Wenzel, S. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [49] Peripheral neuropathy due to neuroborreliosis: Insensitivity for CXCL13 as early diagnostic marker
    Gubanova, Kristina
    Lang, Julia
    Latzko, Juliane
    Novotna, Bianka
    Perneczky, Julian
    Pingitzer, Stefan
    Purer, Petra
    Wuchty, Bianca
    Waiss, Christoph
    Sellner, Johann
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2021, 105 : 460 - 462
  • [50] CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy
    Tokunaga, Ryuma
    Zhang, Wu
    Naseem, Madiha
    Puccini, Alberto
    Berger, Martin D.
    Soni, Shivani
    McSkane, Michelle
    Baba, Hideo
    Lenz, Heinz-Josef
    CANCER TREATMENT REVIEWS, 2018, 63 : 40 - 47
12345